Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Regenxbio (RGNX) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to $142.2 million.

  • Regenxbio's Other Gross PP&E Adjustments rose 566.61% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.2 million, marking a year-over-year increase of 566.61%. This contributed to the annual value of $136.2 million for FY2024, which is 569.85% up from last year.
  • As of Q3 2025, Regenxbio's Other Gross PP&E Adjustments stood at $142.2 million, which was up 566.61% from $140.6 million recorded in Q2 2025.
  • Regenxbio's 5-year Other Gross PP&E Adjustments high stood at $142.2 million for Q3 2025, and its period low was $51.3 million during Q1 2021.
  • Moreover, its 5-year median value for Other Gross PP&E Adjustments was $126.2 million (2023), whereas its average is $117.3 million.
  • As far as peak fluctuations go, Regenxbio's Other Gross PP&E Adjustments soared by 528568.77% in 2021, and later soared by 505.09% in 2024.
  • Quarter analysis of 5 years shows Regenxbio's Other Gross PP&E Adjustments stood at $99.7 million in 2021, then grew by 18.34% to $118.0 million in 2022, then increased by 9.21% to $128.8 million in 2023, then rose by 5.7% to $136.2 million in 2024, then grew by 4.46% to $142.2 million in 2025.
  • Its last three reported values are $142.2 million in Q3 2025, $140.6 million for Q2 2025, and $138.6 million during Q1 2025.